Toll-like Receptor 4 (TLR4) Antagonist Eritoran Tetrasodium Attenuates Liver Ischemia and Reperfusion Injury through Inhibition of High-Mobility Group Box Protein B1 (HMGB1) Signaling
Kerry-Ann McDonald(University of Pittsburgh Medical Center), Allan Tsung(University of Pittsburgh)
Cited by 77
Related Papers
Hepatic Ischemia/Reperfusion Injury Involves Functional TLR4 Signaling in Nonparenchymal Cells
|The Journal of Immunology|2005|361
Neutrophil extracellular traps are indirectly triggered by lipopolysaccharide and contribute to acute lung injury
|Scientific Reports|2016|258
Neutrophils Extracellular Traps Inhibition Improves PD-1 Blockade Immunotherapy in Colorectal Cancer
|Cancers|2021|80
Cisplatin prevents high mobility group box 1 release and is protective in a murine model of hepatic ischemia/reperfusion injury†
|Hepatology|2009|76
Role of interferon regulatory factor-1 in lipopolysaccharide-induced mitochondrial damage and oxidative stress responses in macrophages
|International Journal of Molecular Medicine|2017|39